Associate ProfessorLiesel FitzGerald
Principal Research Fellow
Menzies Institute for Medical Research
Orcid identifier0000-0002-6882-2698 (opens in a new tab)
- Principal Research FellowMenzies Institute for Medical Research
- 6226 4263 (Work)
- Menzies Institute for Medical Research, Menzies Institute for Medical Research, 439b Menzies MS2, Hobart CBD Campuses, TAS
RESEARCH SUMMARy
Research Themes
Assoc Prof FitzGerald’s research aligns with the University’s Better Health research theme. Her research aims to take advantage of the existing Tasmanian familial and case-control prostate cancer resources, consisting of both germline and tumour samples, to identify rare variants associated with risk of disease. This work will lead to better knowledge of the underlying biology involved in prostate cancer development and could identify biomarkers for disease screening as well as genomic targets for novel and existing therapies. This research uses a variety of methodologies including linkage analysis, whole genome sequencing, TaqMan genotyping and gene and protein expression detection techniques.
More recently, Assoc Prof FitzGerald has initiated a Tasmanian clinical and genomics resource, Biomarkers to Improve Outcomes in Prostate Cancer (BIOPC). This resource combines the clinically rich Prostate Cancer Outcomes Registry – Tasmania (PCOR-TAS) with germline and tumour samples from participating prostate cancer cases. Recently there have been major advances in understanding the genomics of prostate cancer risk but there are still significant gaps in understanding why a third of patients’ disease progresses to an aggressive form despite therapeutic intervention, and why some patients respond better than others to particular treatments. The proposed resource will allow us to address these issues, in addition to identifing disparities in diagnosis, treatment and outcomes (clinical and quality-of-life) across Tasmanian prostate cancer patients.
In the era of ‘precision medicine’, through their research Assoc Prof FitzGerald and her colleagues aim to move diagnosis and treatment of patients from a ‘one treatment suits all’ basis to an individual genomics-based approach. Essential components for the delivery of such a system include biospecimens that have been well characterised with clinical, treatment and outcomes data. Through the realisation of Assoc Prof FitzGerald’s research using unique Tasmanian prostate cancer resources, the way men are diagnosed and treated for prostate cancer, as well as disease outcomes, will be significantly improved.
Collaboration
Assoc Prof FitzGerald is participating in several national and international collaborative studies. A key research study that is currently underway with national collaborators, Professors Graham Giles (Cancer Council Victoria) and Melissa Southey (Monash University), aims to identify prognostic biomarkers using diagnostic prostate cancer tissue. Methodologies used in this research study include epigenome-wide methylation and transcriptome-wide gene expression assays. Assoc Prof FitzGerald also has long-standing and on-going research projects with international collaborator, Professor Janet Stanford (Fred Hutchinson Cancer Research Center). Currently, they have two studies underway including a next-generation whole exome sequencing study of prostate cancer families and a prognostic biomarker study that has applied transcriptome-wide gene expression arrays to radical prostatectomy tissue samples.
Awards
Cancer Council Tasmania/College of Health and Medicine Senior Research Fellowship 2018 – 2021
Open to Talent Research Fellowship 2015 – 2018
Cure Cancer/Movember Young Investigator Award 2013 - 2014
David Hill Cancer Council Victoria Fellowship 2012 – 2015
SPORE Post-Doctoral Fellowship 2007 – 2009
ASMR Medical Research Week Finalist 2007
Jeanne Foster Scholarship for professional development in cancer control 2005
Menzies Research Institute PhD Scholarship 2003 – 2006
Queensland Institute of Medical Research Honours Scholarship 1995
Assoc Prof FitzGerald’s research aligns with the University’s Better Health research theme. Her research aims to take advantage of the existing Tasmanian familial and case-control prostate cancer resources, consisting of both germline and tumour samples, to identify rare variants associated with risk of disease. This work will lead to better knowledge of the underlying biology involved in prostate cancer development and could identify biomarkers for disease screening as well as genomic targets for novel and existing therapies. This research uses a variety of methodologies including linkage analysis, whole genome sequencing, TaqMan genotyping and gene and protein expression detection techniques.
More recently, Assoc Prof FitzGerald has initiated a Tasmanian clinical and genomics resource, Biomarkers to Improve Outcomes in Prostate Cancer (BIOPC). This resource combines the clinically rich Prostate Cancer Outcomes Registry – Tasmania (PCOR-TAS) with germline and tumour samples from participating prostate cancer cases. Recently there have been major advances in understanding the genomics of prostate cancer risk but there are still significant gaps in understanding why a third of patients’ disease progresses to an aggressive form despite therapeutic intervention, and why some patients respond better than others to particular treatments. The proposed resource will allow us to address these issues, in addition to identifing disparities in diagnosis, treatment and outcomes (clinical and quality-of-life) across Tasmanian prostate cancer patients.
In the era of ‘precision medicine’, through their research Assoc Prof FitzGerald and her colleagues aim to move diagnosis and treatment of patients from a ‘one treatment suits all’ basis to an individual genomics-based approach. Essential components for the delivery of such a system include biospecimens that have been well characterised with clinical, treatment and outcomes data. Through the realisation of Assoc Prof FitzGerald’s research using unique Tasmanian prostate cancer resources, the way men are diagnosed and treated for prostate cancer, as well as disease outcomes, will be significantly improved.
Collaboration
Assoc Prof FitzGerald is participating in several national and international collaborative studies. A key research study that is currently underway with national collaborators, Professors Graham Giles (Cancer Council Victoria) and Melissa Southey (Monash University), aims to identify prognostic biomarkers using diagnostic prostate cancer tissue. Methodologies used in this research study include epigenome-wide methylation and transcriptome-wide gene expression assays. Assoc Prof FitzGerald also has long-standing and on-going research projects with international collaborator, Professor Janet Stanford (Fred Hutchinson Cancer Research Center). Currently, they have two studies underway including a next-generation whole exome sequencing study of prostate cancer families and a prognostic biomarker study that has applied transcriptome-wide gene expression arrays to radical prostatectomy tissue samples.
Awards
Cancer Council Tasmania/College of Health and Medicine Senior Research Fellowship 2018 – 2021
Open to Talent Research Fellowship 2015 – 2018
Cure Cancer/Movember Young Investigator Award 2013 - 2014
David Hill Cancer Council Victoria Fellowship 2012 – 2015
SPORE Post-Doctoral Fellowship 2007 – 2009
ASMR Medical Research Week Finalist 2007
Jeanne Foster Scholarship for professional development in cancer control 2005
Menzies Research Institute PhD Scholarship 2003 – 2006
Queensland Institute of Medical Research Honours Scholarship 1995
FUNDED PROJECTS
- GRANTUncovering new genetic and epigenetic drivers of brain cancer1 Jul 2026 - 30 Jun 2027People funded by this grant:
- Marshall O,
- Harrup R,
- Dickinson J,
- FitzGerald L
- GRANTCharacterising Rare Prostate Cancer Risk Variants using a Prostate Organoid ModelCancer Council of Tasmania1 Mar 2026 - 28 Feb 2027People funded by this grant:
- FitzGerald L,
- Raspin K,
- Smalley E,
- Dickinson J
- GRANTUncovering the genetic drivers of brain cancer in Tasmanians1 Jan 2026 - 30 Jun 2027People funded by this grant:
- Marshall O,
- Harrup R,
- Dickinson J,
- Thani N,
- FitzGerald L
- GRANTUnderstanding the Genetics of Prostate Cancer to Improve Diagnosis and Treatment Strategies1 Jan 2026 - 31 Dec 2026People funded by this grant:
- FitzGerald L
- GRANTEvaluating respondent burden for the EQ-HWB and EQ-HWB-S in prostate cancer1 Aug 2025 - 31 Jul 2027People funded by this grant:
- Roydhouse J,
- Finch A,
- FitzGerald L,
- Breslin M,
- Norman R
- CONSULTANCY/CONTRACT RESEARCHPreventing Disease Progression in Prostate Cancer1 Aug 2025 - 31 Dec 2026People funded by this grant:
- FitzGerald L,
- Sweeney C
- GRANTImplementing Patient-Reported Outcome Collection in Routine Prostate Cancer Care in Rural and Regional Settings31 Mar 2025 - 29 Feb 2028People funded by this grant:
- Roydhouse J,
- Van Dam P,
- Jose K,
- Zhao T,
- FitzGerald L
- GRANTThe Absolute Q digital PCR system from Applied Biosystems to help improve clinical pathways and outcomes for all Tasmanians1 Jul 2024 - 30 Jun 2025People funded by this grant:
- Raspin K,
- FitzGerald L
- GRANTDiscovery of Rare Prostate Cancer Risk Variants to Innovate Gene-Based Clinical Tests1 Mar 2024 - 31 Aug 2026People funded by this grant:
- FitzGerald L,
- Dickinson J,
- Raspin K
- GRANTBringing Precision in Prostate Cancer Medicine to Tasmania1 Jan 2024 - 31 Dec 2025People funded by this grant:
- Raspin K,
- Roydhouse J,
- Dickinson J,
- FitzGerald L,
- Nott L
- GRANTIdentifying key drivers of metastatic bone lesions from several cancer types.1 Jun 2023 - 30 Jun 2024People funded by this grant:
- Raspin K,
- Dickinson J,
- FitzGerald L,
- Nott L
- GRANTA Clinical and Biospecimens Prostate Cancer Resource for Biomarker Research in Tasmania1 Jan 2023 - 30 Jun 2024People funded by this grant:
- FitzGerald L,
- Dickinson J,
- Skala M,
- Donovan S,
- Harris H
- GRANTClosing the Health Gap: Precision Care for Men with Prostate Cancer (PC4PC-TAS)Royal Hobart Hospital Research Foundation1 Jan 2023 - 31 Dec 2027People funded by this grant:
- Raspin K,
- Dickinson J,
- Roydhouse J,
- Wallis M,
- Lucas S
- GRANTDonation - Prostate cancer research28 Feb 2022 - 28 Feb 2026People funded by this grant:
- FitzGerald L
- GRANTPrecision Medicine for Men with Prostate Cancer1 Jan 2022 - 31 Mar 2024People funded by this grant:
- Dickinson J,
- Roydhouse J,
- Raspin K,
- FitzGerald L,
- Harrup R
- GRANTUnderstanding TMPRSS2:ERG gene fusions to improve prostate cancer diagnosis and treatment options1 Jan 2022 - 31 Dec 2023People funded by this grant:
- FitzGerald L,
- Dickinson J,
- Raspin K
- GRANTEnhancing PCOR-ANZ using Data Linkage: A Pathfinder Pilot14 Jul 2021 - 4 Apr 2024People funded by this grant:
- Roder D,
- Buckley E,
- Beckman K,
- Moretti K,
- FitzGerald L
- GRANTAdvancing Precision Medicine for Men Diagnosed with Prostate Cancer1 Jul 2021 - 30 Jun 2022People funded by this grant:
- Raspin K,
- Dickinson J,
- FitzGerald L,
- Marthick J
- GRANTApplying innovative 'omics' technologies to identify key molecular drivers of metastatic bone tumours1 Jul 2021 - 30 Jun 2022People funded by this grant:
- Raspin K,
- Dickinson J,
- FitzGerald L,
- Holloway A
- CONSULTANCY/CONTRACT RESEARCHBiomarkers to improve outcomes in prostate cancer (BIOPC)1 Jan 2021 - 31 Dec 2022People funded by this grant:
- FitzGerald L,
- Townley J,
- Marthick J
- GRANTDNA Damage Repair Gene Variants in Clinically Significant Prostate Cancer1 Jan 2021 - 31 Dec 2021People funded by this grant:
- Dickinson J,
- FitzGerald L
- GRANTReal-world outcomes and toxicities for patients with non-small cell lung cancer receiving immunotherapy1 Jan 2021 - 31 Jul 2022People funded by this grant:
- Roydhouse J,
- Tay R,
- Nott L,
- Black A,
- Grundy R
- GRANTUtilising large Tasmanian families to determine the impact of rare genetic variation on prostate cancer.1 Jan 2021 - 30 Jun 2024People funded by this grant:
- FitzGerald L,
- Dickinson J,
- Skala M,
- Donovan S,
- Redwig F
- GRANTA Clinical and Biospecimens Prostate Cancer Resource for Biomarker Research in Tasmania1 Jan 2020 - 31 Oct 2022People funded by this grant:
- FitzGerald L,
- Dickinson J,
- Jones M,
- Donovan S,
- Murdolo V
- GRANTGaining new insights into metastatic bone tumours1 Jan 2020 - 30 Jun 2021People funded by this grant:
- Dickinson J,
- Holloway A,
- Nott L,
- Liu G-S,
- FitzGerald L